Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Moingeon

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Allergy|December 14, 2011
Sublingual allergen immunotherapy: mode of action and its relationship with the safety profileM A Calderón, F E R Simons, H-J Malling, et al.
Blood|March 1, 1986
Short-term culture of acute myeloid leukemia blasts: analysis of acquired susceptibility to activated natural killer cellsP Moingeon, A Ythier, A Nowill, et al.
Biochemical Pharmacology|May 15, 1985
Ellipticine derivatives interact with muscarinic receptorsG F Alberici, J M Bidart, P Moingeon, et al.
Life Sciences|November 12, 1984
Benzodiazepine receptors on human blood plateletsP Moingeon, J J Dessaux, R Fellous, et al.
Immunological Reviews|October 1, 1989
The structural biology of CD2P Moingeon, H C Chang, P H Sayre, et al.
The Journal of Experimental Medicine|July 1, 1992
The CD3 zeta cytoplasmic domain mediates CD2-induced T cell activationF D Howard, P Moingeon, U Moebius, et al.
Gene Therapy|November 20, 2003
Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2)T-M Jourdier, C Moste, M-C Bonnet, et al.
The Journal of Experimental Medicine|April 1, 1993
Fc gamma RII/III and CD2 expression mark distinct subpopulations of immature CD4-CD8- murine thymocytes: in vivo developmental kinetics and T cell receptor beta chain rearrangement statusH R Rodewald, K Awad, P Moingeon, et al.
Vaccine|February 13, 2001
Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaquesB Rosenwirth, E M Kuhn, J L Heeney, et al.
Transplantation|September 1, 1986
Characterization of antileukemia cells' cytotoxic effector function. Implications for monitoring natural killer responses following allogeneic bone marrow transplantationL Delmon, A Ythier, P Moingeon, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Allergy|December 14, 2011
Sublingual allergen immunotherapy: mode of action and its relationship with the safety profileM A Calderón, F E R Simons, H-J Malling, et al.
Blood|March 1, 1986
Short-term culture of acute myeloid leukemia blasts: analysis of acquired susceptibility to activated natural killer cellsP Moingeon, A Ythier, A Nowill, et al.
Biochemical Pharmacology|May 15, 1985
Ellipticine derivatives interact with muscarinic receptorsG F Alberici, J M Bidart, P Moingeon, et al.
Life Sciences|November 12, 1984
Benzodiazepine receptors on human blood plateletsP Moingeon, J J Dessaux, R Fellous, et al.
Immunological Reviews|October 1, 1989
The structural biology of CD2P Moingeon, H C Chang, P H Sayre, et al.
The Journal of Experimental Medicine|July 1, 1992
The CD3 zeta cytoplasmic domain mediates CD2-induced T cell activationF D Howard, P Moingeon, U Moebius, et al.
Gene Therapy|November 20, 2003
Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2)T-M Jourdier, C Moste, M-C Bonnet, et al.
The Journal of Experimental Medicine|April 1, 1993
Fc gamma RII/III and CD2 expression mark distinct subpopulations of immature CD4-CD8- murine thymocytes: in vivo developmental kinetics and T cell receptor beta chain rearrangement statusH R Rodewald, K Awad, P Moingeon, et al.
Vaccine|February 13, 2001
Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaquesB Rosenwirth, E M Kuhn, J L Heeney, et al.
Transplantation|September 1, 1986
Characterization of antileukemia cells' cytotoxic effector function. Implications for monitoring natural killer responses following allogeneic bone marrow transplantationL Delmon, A Ythier, P Moingeon, et al.
Pageof 9